The promise and limitations of TNF-α inhibition for uveitis

Ocul Immunol Inflamm. 2014 Apr;22(2):87-9. doi: 10.3109/09273948.2014.894766.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Arthritis, Juvenile / complications*
  • Female
  • Humans
  • Infliximab
  • Male
  • Uveitis / drug therapy*
  • Uveitis, Anterior / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • golimumab
  • Infliximab
  • tocilizumab